To buy shares in Theravance Biopharma Inc. you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $9.14 to buy one share in Theravance Biopharma Inc. (as of 16:00 15-May-2025). Which is a change of $0.73 or 8.68% from the last closing price of $8.41.
How To Buy Theravance Biopharma Inc. Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Theravance Biopharma Inc.:
- Pick a stock broker (jump down to compare the best brokers for buying Theravance Biopharma Inc. stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:TBPH)
- Choose the number of shares you want to buy (1 share currently costs $9.14)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Theravance Biopharma Inc. stock in your account (this will show your profit and loss)
Theravance Biopharma Inc. Share Price (TBPH) Quote & Overview
This section shows the most important aspects of the current Theravance Biopharma Inc. TBPH:US share price including price, change, bid/offer spread and volume.
- Theravance Biopharma Inc. is currently worth $457,012,173 based on the last closing price of $8.41 with 360,884 shares traded.
- The most recent Theravance Biopharma Inc. daily high has been $9.15 and daily low $8.4.
- The Theravance Biopharma Inc. stock price 52 week high has been $10.9 and the 52 week low $7.44.
Compare Brokers For Buying Theravance Biopharma Inc. Stock
It’s usually commission-free to buy US stocks as American stock brokers make their money from payment for order flow. However, there can sometimes be additional charges for buying stocks in an IRA, where your contributions are tax-deductible.
| US Stock Broker | US Stocks Available | Dealing Commission | Margin Rates | Customer Reviews | More Info |
|---|---|---|---|---|---|
 | 17,913 | 0.003% | 5.33% – 6.33% | (Based on 934 reviews)
| Visit Broker Your capital is at risk |
 | 6,000+ | 0% | 0% | (Based on 144 reviews)
| Visit Broker Your capital is at risk |
 | 5,000+ | 0% | 8% – 11% | (Based on 0 reviews)
| Read Reviews |
 | 4,000+ | 0% | 10.2% – 13.2% | (Based on 1 reviews)
| Read Reviews |
 | 4,000+ | 0% | 8.575% – 13.075% | (Based on 22 reviews)
| Read Reviews |
 | 5,000+ | 0% | 8% (Flat) | (Based on 23 reviews)
| Read Reviews |
 | 7,000+ | 0% | 8.5% – 12.075% | (Based on 0 reviews)
| Read Reviews |
 | 5,000+ | 0% | 9.49% (Flat) | (Based on 0 reviews)
| Read Reviews |
Is Now A Good Time To Buy Theravance Biopharma Inc. Stock?
For expert analysis join Good Money Guide Premium.
- Theravance Biopharma Inc.’s EPS (earnings per share) are -1.19. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Theravance Biopharma Inc.’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Theravance Biopharma Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.
Theravance Biopharma Inc. (TBPH) Analysis
This section shows analysis for Theravance Biopharma Inc. TBPH:US. It shows analyst rating, recommnedations and history, as well industry ranking comparison.
Theravance Biopharma Inc. (TBPH) Earnings Estimates & Forecasts
This section shows how analysts expect the Theravance Biopharma Inc. TBPH:US share price to perform in the future based on their earnings reports and estimates. It gives an overview of future short, long and medium term price targets as well as previous earnings reports.
Theravance Biopharma Inc. (TBPH) Company Financials
This section shows current and previous Theravance Biopharma Inc. TBPH:US profit and loss information like revenue, income, expenses and earnings per share.
Theravance Biopharma Inc. (TBPH) Financial Summary
This section allows you to compare Theravance Biopharma Inc. TBPH:US revenue, net income, cash flow statement and balance sheet against previous years. This can give you a good indication of how well a company is performing.
Theravance Biopharma Inc. (TBPH) Share Price History
This section provides a visual and table view of the historic Theravance Biopharma Inc. TBPH:US share price including volume and VWAP which can be adjusted for splits and dividends.
Theravance Biopharma Inc. (TBPH) Interactive Chart
This section allows you to compare Theravance Biopharma Inc. TBPH:US share price chart against other stocks as well as overlay key events like dividends, earnings and splits.
Theravance Biopharma Inc. (TBPH) Dividends
This section analyses the historic and upcoming Theravance Biopharma Inc. TBPH:US dividend amounts, dates and yields. It provides a good indication of potential future and past profitability.
Theravance Biopharma Inc. (TBPH) Corporate Events
This section shows key dates in Theravance Biopharma Inc. TBPH:US corporate calendar like company announcements, earnings releases, stock splits, and fundamental data chances like EPS updates.
Theravance Biopharma Inc. (TBPH) Share Price Performance
This section shows key Theravance Biopharma Inc. TBPH:US share price levels like recent highs and lows, plus gives you tools to see average day traded volumes and institutional share holders major buys and sells.
Theravance Biopharma Inc. (TBPH) Share Price News
This section shows new stories that are relevant to and may effect or explain changes in Theravance Biopharma Inc. TBPH:US share price.
Theravance Biopharma Inc. (TBPH) Company Profile
This section provides corporate information on Theravance Biopharma Inc. TBPH:US, including what they do, their contact details, their CEO and auditor as well as in what sectors their shares trade.
